Does grip strength decrease in the very early stages of hematological treatment?
- 196 Downloads
Muscle weakness in hematological cancer patients undergoing acute stages of treatment is an important concern and strong predictor of poor outcomes. However, evidence of strength loss in the very early stages of cancer treatment is not addressed. Here, we found that grip strength was compromised within the first 7 days of hematological treatment (− 2.3 kg, P = 0.002). These findings are novel in elucidating lower handgrip strength in the first week of hematological treatment and encourage additional research focusing on handgrip strength in oncology patients under initial high-dose chemotherapy routine.
KeywordsMuscle strength Hematology Cancer Physical function
Compliance with ethical standards
The study was approved by the local Human Research Ethics committee (#1.576.178) and all patients obtained informed written consent.
Conflict of interest
The authors declare that they have no conflict of interest.
- 1.Alibhai SM, Breunis H, Timilshina N, Brignardello-Petersen R, Tomlinson G, Mohamedali H et al (2015) Quality of life and physical function in adults treated with intensive chemotherapy for acute myeloid leukemia improve over time independent of age. J Geriatr Oncol 6:262–271CrossRefPubMedGoogle Scholar
- 3.Murnane A, Keogh J, Magat F, Imbesi S, Coulombe M, Patchell S et al (2015) The impact of an inpatient hospital admission on patients’ physical functioning and quality of life in the oncology setting. J Nurs Educ Pract 5:75–82Google Scholar
- 9.Kilgour RD, Vigano A, Trutschnigg B, Lucar E, Borod M, Morais JA (2013) Handgrip strength predicts survival and is associated with markers of clinical and functional outcomes in advanced cancer patients. Support Care Cancer : Off J Multinat Assoc Support Care Cancer 21:3261–3270CrossRefGoogle Scholar
- 10.Lakenman P, Ottens-Oussoren K, Witvliet-van Nierop J, van der Peet D, de van der Schueren M (2017) Handgrip Strength Is Associated With Treatment Modifications During Neoadjuvant Chemoradiation in Patients With Esophageal Cancer Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition: 884533617700862Google Scholar
- 11.Kramer M, Heussner P, Herzberg PY, Andree H, Hilgendorf I, Leithaeuser M et al (2013) Validation of the grip test and human activity profile for evaluation of physical performance during the intermediate phase after allogeneic hematopoietic stem cell transplantation. Support Care Cancer: Off J Multinat Assoc Support Care Cancer 21:1121–1129CrossRefGoogle Scholar
- 12.Morishita S, Kaida K, Yamauchi S, Sota K, Ishii S, Ikegame K et al (2013) Relationship between corticosteroid dose and declines in physical function among allogeneic hematopoietic stem cell transplantation patients. Support Care Cancer: Off J Multinat Assoc Support Care Cancer 21:2161–2169CrossRefGoogle Scholar
- 15.Fess EE (1992) Clinical assessment recommendations. In: JS IC (ed) American society of hand therapist, pp. 41–45Google Scholar
- 20.Bergenthal N, Will A, Streckmann F, Wolkewitz KD, Monsef I, Engert A et al (2014) Aerobic physical exercise for adult patients with haematological malignancies. Cochrane database Syst Rev 11:CD009075Google Scholar